We did observe a significant difference in median FOLR1 expression between patients age (≤60, P = 0.002) when analysis was performed across all breast cancer subtypes (S2 Table), but this significance was lost when analysis was limited to TNBC tumors (S3 Table). This evidence concerns the gene FOLR1 and breast cancer.